Palo Alto Investors LP Mirum Pharmaceuticals, Inc. Transaction History
Palo Alto Investors LP
- $626 Million
- Q4 2024
A detailed history of Palo Alto Investors LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 64,700 shares of MIRM stock, worth $3.24 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
64,700
Previous 64,700
-0.0%
Holding current value
$3.24 Million
Previous $2.52 Million
6.02%
% of portfolio
0.43%
Previous 0.35%
Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
208Shares Held
54MCall Options Held
64.1KPut Options Held
117K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$329 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$229 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$162 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$140 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$130 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.84B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...